Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 10—October 2003
Perspective

Syndromic Surveillance and Bioterrorism-related Epidemics

James W. Buehler*Comments to Author , Ruth L. Berkelman*, David M. Hartley†, and Clarence J. Peters‡
Author affiliations: *Emory University Rollins School of Public Health, Atlanta, Georgia, USA; †University of Maryland School of Medicine, Baltimore, Maryland, USA; ‡University of Texas Medical Branch, Galveston, Texas, USA

Main Article

Table 1

Outcome of initial contact with health care for anthrax-related illness and timing of anthrax diagnosis, 11 patients with inhalational anthrax, 2001a

Disposition after initial medical care No. of patients
Admitted to hospital
 7
          Discharged home from ER, subsequent hospital admission
 2
          Discharged home from outpatient provider, subsequent hospital admission
 2
Total
 11
Anthrax diagnosis
          Blood or CSF culture on hospital admission, presumptive diagnosis <24 h
 7
          Blood culture from preceding ER visit, patient recalled for admission
 1
          Prior antibiotic therapy; clinical suspicion of anthrax; specialized test required to establish diagnosis
 3
          Total 11

aER, emergency room; CSF, cerebrospinal fluid.

Main Article

1For interval calculations, if reported event dates were discrepant in different case reports, dates reported by Jernigan et al. (13) were used.

Page created: January 10, 2011
Page updated: January 10, 2011
Page reviewed: January 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external